Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Labmate ApS

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.1%   Bankruptcy risk   11.1% 11.1% 5.9% 9.1% 16.8% 13.9% 10.8% 6.6%   Credit score (0-100)   24 23 41 27 9 15 22 12   Credit rating   B B BB B B B B BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   419 214 387 424 288 306 0.0 0.0   EBITDA   419 214 387 424 288 306 0.0 0.0   EBIT   419 214 387 424 288 306 0.0 0.0   Pre-tax profit (PTP)   472.8 184.4 388.8 428.4 268.4 291.3 0.0 0.0   Net earnings   368.8 142.4 303.1 333.5 208.5 226.7 0.0 0.0   Pre-tax profit without non-rec. items   473 184 389 428 268 291 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   581 670 919 1,197 1,349 1,519 1,410 1,410   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0   Balance sheet total (assets)   1,123 1,087 1,412 1,739 1,503 1,679 1,410 1,410   Net Debt   -200 -228 -575 -305 -41.6 -86.1 -1,410 -1,410     See the entire balance sheet 1000.0 Volume  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   419 214 387 424 288 306 0.0 0.0   Gross profit growth   42.0% -49.0% 81.3% 9.6% -32.2% 6.4% -100.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,123 1,087 1,412 1,739 1,503 1,679 1,410 1,410   Balance sheet change%   313.4% -3.2% 30.0% 23.1% -13.5% 11.7% -16.0% 0.0%   Added value   419.0 213.6 387.2 424.4 287.9 306.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   70.1% 19.3% 32.0% 28.0% 17.8% 19.3% 0.0% 0.0%   ROI %   123.3% 34.2% 50.3% 41.7% 22.6% 21.4% 0.0% 0.0%   ROE %   93.1% 22.8% 38.1% 31.5% 16.4% 15.8% 0.0% 0.0%   1000.0 Solidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Equity ratio %   51.7% 61.7% 65.1% 68.9% 89.7% 90.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -47.7% -106.8% -148.4% -71.8% -14.5% -28.1% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.1% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.0% 1,822.1% 0.0% 0.0%   1000.0 Liquidity  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Quick Ratio   2.1 2.6 2.9 3.2 9.8 10.5 0.0 0.0   Current Ratio   2.1 2.6 2.9 3.2 9.8 10.5 0.0 0.0   Cash and cash equivalent   199.7 228.0 574.7 304.7 41.6 87.8 0.0 0.0   1000.0 Capital use efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   580.6 670.1 919.1 1,197.4 1,349.4 1,518.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023e N/A 2024e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0